viernes, 9 de marzo de 2018

Announcing the CDER SBIA REdI: Generic Drugs Forum April 11-12, 2018

CDER Small Business and Industry Assistance (SBIA) invites you to the free two-day FDA led Regulatory Education for Industry (REdI): Generic Drugs Forum 2018.  Join us to learn from and interact with FDA subject matter experts involved in the Generic Drug Review Program.

Our agenda covers over 20 topics, including a Pharmaceutical Quality Update; Determining Whether to Submit an ANDA or a 505(b)(2) Application; Laboratory Science to Support Risk-Based Quality Assessments; and more…

Keynote speaker: Dr. Kathleen Uhl, Director of the Office of Generic Drugs.

*  Conference Webpage  *  Registration  *  Agenda  *

                                                            What: SBIA REdI Generic Drugs Forum

                                                            When: April 11-12, 2018

                                                            Where: On-site in Silver Spring, MD, 

                                                                          or virtually online via Adobe Connect.

Advance registration is required. 

We ask that you please honor your registration commitment to help us plan this conference efficiently. If you need to change your registration status, please email us at

This conference has been pre-approved by RAPS as eligible for up to 

12 credits towards a participant’s RAC recertification upon full completion. 

A MUST ATTEND event for all professionals involved with the generic drug industry!

No hay comentarios: